Researchers examined stage IV gastric cancer outcomes after palliative gastrectomy involving lymph node dissection. A higher count of retrieved lymph nodes did not increase 30-day complication or mortality rates, News-Medical reported.
Systemic anticancer therapy remains the primary treatment for stage IV disease. Palliative surgery is typically reserved for managing symptoms like bleeding or gastric outlet obstruction.
The study was spearheaded by Professor Sang-Ho Jeong from the Department of Surgery at Gyeongsang National University Changwon Hospital alongside Professor Jae-Seok Min of the Division of Foregut Surgery within the Department of Surgery at Korea University Anam Hospital. They analyzed 855 patients identified from the Korean Gastric Cancer Association registries for 2019 and 2023.
The study divided patients into two cohorts based on lymph node counts. The limited-dissection group included 62 patients with fewer than 15 nodes retrieved. The extended-dissection group contained 793 patients with 15 or more nodes removed.
Initial unadjusted figures showed higher 30-day complication rates in the limited group at 43.5%. The extended group recorded a 29.8% complication rate.
Unadjusted 30-day mortality reached 17.7% for limited dissection and 6.8% for extended dissection. Researchers said that the limited-dissection group contained more patients with poorer physical status who underwent open surgery or total gastrectomy.
To account for initial disparities in sex, age, BMI, American Society of Anesthesiologists physical status, surgical approach, extent of gastric resection, combined organ resection, comorbidities, and neoadjuvant chemotherapy, researchers utilized propensity score weighting. Weighted 30-day complication rates were 45.1% for limited dissection and 30.9% for extended dissection. Weighted mortality rates were 19.7% and 7.8% respectively.
Pneumonia showed the largest weighted difference in individual complications at 14.8% versus 3.7%. Anastomotic leakage, duodenal stump leakage, and intra-abdominal abscess were also numerically more frequent in the limited group.
Statistical models associated extended dissection with lower odds of complications and mortality. However, the team cautioned that observational findings do not prove extended dissection is safer or curative.
“Our study does not mean that removing more lymph nodes during palliative gastrectomy for stage IV gastric cancer reduces complication rates,” said Professor Jae-Seok Min, telling News-Medical that treatment decisions should be based on a comprehensive assessment of the patient’s overall health, disease extent, and ability to receive subsequent anticancer therapy. Careful perioperative management, including attention to pneumonia prevention, is also essential.
Palliative gastrectomy is a surgical procedure considered for selected stage IV gastric cancer patients experiencing symptoms like bleeding or gastric outlet obstruction that prevent adequate food intake.
Patients undergoing open procedures or total gastrectomy, as well as those with worse preoperative physical health, made up a larger share of the limited-dissection group.
Although researchers stressed that the results do not prove an extended dissection offers a therapeutic advantage, a greater count of retrieved lymph nodes did not correlate with elevated 30-day rates of mortality or surgical complications.